JOINN LABORATORIES(CHINA)CO.,LTD. Funds and ETFs Joinn Laboratories(China)Co.,Ltd.
Equities
603127
CNE100002W27
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.37 CNY | +2.72% |
|
+3.52% | -26.74% |
ETFs positioned on Joinn Laboratories(China)Co.,Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.46% | 2 M€ | -16.59% | - | |
| 0.03% | 2 M€ | -.--% | ||
| 0.01% | 7 M€ | -.--% | - | |
| 0.00% | 117 M€ | +1.11% | - | |
| 0.00% | 2,808 M€ | +5.90% | - | |
| 0.00% | 441 M€ | +4.60% | - | |
| 0.00% | 149 M€ | +2.17% | - | |
| 0.00% | 34 M€ | +2.14% | - | |
| 0.00% | 15 M€ | +11.24% |
Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The Company conducts its businesses both in the domestic market and overseas markets.
Calendar
2024-04-28
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
17.37
CNY
Average target price
19.29
CNY
Spread / Average Target
+11.06%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -26.74% | 1.66B | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- 603127 Stock
- Funds and ETFs Joinn Laboratories(China)Co.,Ltd.
